Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Thyroid Neoplasms × Iodine-123 × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Parkinson Disease 1 Neuroendocrine Tumors 1

Interventions

Iodine-131 2 Thyroidectomy 1 Surgical Procedures, Operative 1 Sorafenib 1 Radiotherapy, Intensity-Modulated 1 Iodine-123 1 Anterior Temporal Lobectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02418247 2017-01-20

Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer

National Cancer Center, Korea

Phase 2/3 Unknown

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡